InvestSMART

Terragen Holdings Limited (ASX:TGH)

ALERT: Price-sensitive ASX Announcement for TGH
Current share price for TGH : $0.013 -0.01 (-43.48%)+
Release
25 Aug 2026 3:17PM
Price at Release
$0.023
Full Release
download
Summary
Terragen Holdings Limited's Annual Report for the fiscal year ended June 30, 2026, highlights a substantial increase in net assets to $9,502,693 from the previous year's $6,569,265 despite a loss of $3,751,367. The company issued over 318 million new shares, bolstering its capital, and reported total revenue from customers at $1,393,797. A notable rise in research and development expenses was seen, alongside a share-based payments expense of $117,781. Cash reserves grew to $7,253,956, and total liabilities were recorded at $1,089,726. The leadership team includes prominent figures such as Dr. Michele Allan AO.
Key Points
  • Terragen Holdings Limited reported a total equity of $9,502,693 as of 30 June 2026.
  • Net assets increased from $6,569,265 in 2025 to $9,502,693 in 2026.
  • The company recorded a loss of $3,751,367 for the year ended 30 June 2026.
  • Total revenue from customers amounted to $1,393,797.
  • Research and development expenses increased to $1,224,905.
  • The company issued 318,181,819 new shares during the year.
  • The share-based payments expense for the year was $117,781.
  • The company's cash and cash equivalents increased to $7,253,956.
  • Terragen Holdings Limited had total liabilities of $1,089,726 as of 30 June 2026.
  • The board of directors includes Dr. Michele Allan AO and Mr. Scobie Ward among others.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.